Drug Shortage Report for ALVESCO

Last updated on 2018-10-23 History
Report ID 59166
Drug Identification Number 02285614
Brand name ALVESCO
Common or Proper name ciclesonide
Company Name ASTRAZENECA CANADA INC
Active Ingredient(s) CICLESONIDE
Strength(s) 200MCG
Dosage form(s) AEROSOL, METERED DOSE
Route of administration INHALATION
Packaging size 30 doses
ATC code R03BA
ATC description OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS
Reason for shortage Shortage of an inactive ingredient or component.
Anticipated start date 2018-09-01
Actual start date 2018-09-01
Estimated end date 2018-11-01
Actual end date 2018-10-22
Shortage status Resolved
Updated date 2018-10-23
Company comments
Health Canada comments
Company contact information Please contact AstraZeneca Canada Medical Information for any specific questions at 1-800-668-6000 (EN) or 1-800-461-3787 (FR) or by email: medinfo.canada@astrazeneca.com.

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2018-10-23 English Compare
v10 2018-10-22 French Compare
v9 2018-10-22 English Compare
v8 2018-09-21 French Compare
v7 2018-09-21 English Compare
v6 2018-09-04 French Compare
v5 2018-09-04 English Compare
v4 2018-09-02 English Compare
v3 2018-08-25 French Compare
v2 2018-08-25 English Compare
v1 2018-08-25 English Compare